Tissue engineered heart valves based on human cells

Swiss Medical Weekly

Volumn 136, Issue 39-40, 2006, Pages 618-623

  Schmidt, Dörthe ^a   Hoerstrup, Simon Philipp ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bone marrow cells; Chorionic villi cells; Heart valves; Tissue engineering; Umbilical cord cells

Indexed keywords

ALLOGRAFT; BLOOD CELL; BONE MARROW CELL; CHORION VILLUS; ENDOTHELIUM CELL; HEART VALVE; HEART VALVE REPLACEMENT; HUMAN; SHORT SURVEY; STEM CELL; STROMA CELL; TISSUE ENGINEERING; UMBILICAL CORD; VALVULAR HEART DISEASE; XENOGRAFT;

EID: 33751007854     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (33)

1. Schoen FJ. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis 1997;6:1-6.
2. Hammermeister K, Sethi GK, Huderson WG, Grover FL, Oprian C, Rahimtoola SH, et al. Outcomes 15 years after valve replacement with a mechanical versus bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-8.
3. Senthilnathan V, Treasure T, Grunkemayer G, Starr A. Heart valves: which is the best choice? Cardiovasc Surg 1999;7:393-7.
4. Mayer J. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Seminars in Thoracic and Cardiovascular Surgery 1995;7:130-2.
5. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999.
6. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999;47: 439-65.
7. Endo S, Saito N, Misawa Y, Sohara Y. Late pericarditis secondary to pericardial patch implantation 25 years prior. Eur J Cardiothorac Surg 2001:1059-60.
8. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:513-6.
9. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998;14:279-84.
10. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102:III44-49.
11. Elkins RC, Goldstein S, Hewitt C, Walsh SP, Dawson PE, Ollerenshaw JD, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 2001;13:87-92.
12. Shinoka T, Breuer C, Tannel RE, Zund G, Miura T, Ma PX, et al. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:513-6.
13. Langer R, Vacanti JP. Tissue engineering. Science 1993;260: 920-6.
14. Matheny RG, Hutchison ML, Dryden PE, Hilles MD, Shaar CJ. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J Heart Valve Dis 2000;9:769-75.
15. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-6.
16. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomedic Mat Res 2001; 55:141-50.
17. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Meyer JE Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng 2000;6:75-9.
18. Mol A, Bouten CV, Zund G, Gunter CI, Visjager JF, Turina MI, et al. The relevance of large strains in functional tissue engineering of heart valves. Thorac Cardiovasc Surg 2003;51:78-83.
19. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science 1999;284:489-93.
20. Zund G Breuer CK, Shinoka T, Ma PX, Langer R, Mayer JE, Vacanti JP. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 1997;11:493-7.
21. Rabkin E, Hoerstrup SP, Aikawa M, Mayer JE, Schoen FJ. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and remodeling. J Heart Valve Disease 2002;11:308-14.
22. Hoerstrup SP, Zund G, Schoeberlein A, Ye Q, Vogt PR, Turina MI. Fluorescence activated cell sorting: a reliable method in tissue engineering of a bioprosthetic heart valve. Ann Thorac Surg 1998;66:1653-7.
23. Zund G, Hoerstrup SP, Schoeberlein A, Lachat M, Uhlschmid G, Vogt PR, et al. Tissue engineering: a new approach in cardiovascular surgery: Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh. Eur J Cardiothorac Surg 1998;13:160-4.
24. Schnell AM, Hoerstrup SP, Zund G, Kolb S, Sodian R, Visjager JF, et al. Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg 2001;49:221-5.
25. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002;106: 1-143-50.
26. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, et al. Mesenchymal stem cells in Wharton's Jelly of the human umbilical cord. Stem Cells 2004;22:1330-7.
27. Sarugaser R, Lickerish D, Baksh D, Hosseini M, Davies JE. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitor cells. Stem Cells 2005;23:220-9.
28. Hoerstrup SP, Kadner A, Breymann CI, Maurus CF, Guenter CI, Sodian R, et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg 2002;74:46-52.
29. Schmidt D, Breymann C, Weber A, Guenter CI, Neuenschwander S, Zund G, et al. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of Vascular Grafts. Ann Thorac Surg 2004;78:2094-8.
30. Schmidt D, Mol A, Neuenschwander S, Breymann C, Gössi M, Zund G, et al. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 2005;27:795-800.
31. Dvorin EL, Wylie-Sears J, Kaushal S, Martin DP, Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Tissue Eng 2003;9:487-93.
32. Schmidt D, Mol A, Breymann C, Achermann J, Odermatt B, Gössi M, et al. Living autologous heart valves engineered from prenatally harvested progenitors. Circulation 2006;114: 1125-31.
33. Cebotari A, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006;114:1132-37.